stella
beta
Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC — Stella
Recruiting
Back to Extensive-stage Small Cell Lung Cancer (ES-SCLC) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Anhui Cancer Hospital, Hefei, Anhui
View full record on ClinicalTrials.gov